UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000047270
Receipt No. R000053896
Scientific Title Effect of high dose SGLT-2 inhibitor on fatty liver
Date of disclosure of the study information 2022/03/23
Last modified on 2022/03/23 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of high dose SGLT-2 inhibitor on fatty liver
Acronym Effect of high dose SGLT-2 inhibitor on fatty liver
Scientific Title Effect of high dose SGLT-2 inhibitor on fatty liver
Scientific Title:Acronym Effect of high dose SGLT-2 inhibitor on fatty liver
Region
Japan

Condition
Condition type2 diabetes/fatty liver
Classification by specialty
Hepato-biliary-pancreatic medicine Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To determine whether high dose SGLT-2 inhibitor improves fatty liver in diabetic patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Compare AST, ALT, FIB-4 index, and NAFLD fibrosis score (NFS) before and after treatment in patients receiving high dose SGLT-2 inhibitor for at least 6 months
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Diabetic patients whose HbA1C does not improve with regular doses of SGLT-2 inhibitor and who have started higher doses SGLT-2 inhibitor
Key exclusion criteria Patients who have completed less than 6 months of high-dose SGLT-2 inhibitor therapy
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Hironori
Middle name
Last name Konuma
Organization Konuma Internal medicine Gastroenterology Clinic
Division name directer
Zip code 329-2722
Address 6-42 Nishiasahityo,Nasushiobara city,Tochigi,Japan
TEL 0287375353
Email hkonuma.drdr@gmail.com

Public contact
Name of contact person
1st name Hironori
Middle name
Last name Konuma
Organization Konuma Internal medicine Gastroenterology Clinic
Division name directer
Zip code 329-2722
Address 6-42 Nishiasahityo,Nasushiobara city,Tochigi,Japan
TEL 0287375353
Homepage URL
Email hkonuma.drdr@gmail.com

Sponsor
Institute Konuma Internal medicine Gastroenterology Clinic
directer
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Konuma Internal medicine Gastroenterology Clinic
Address 6-42 Nishiasahityo,Nasushiobara city,Tochigi,Japan
Tel 0287375353
Email hkonuma.drdr@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 小沼内科胃腸科クリニック(栃木県)

Other administrative information
Date of disclosure of the study information
2022 Year 03 Month 23 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 20
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2021 Year 01 Month 04 Day
Date of IRB
2021 Year 03 Month 12 Day
Anticipated trial start date
2021 Year 01 Month 05 Day
Last follow-up date
2022 Year 08 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2022 Year 03 Month 23 Day
Last modified on
2022 Year 03 Month 23 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053896